Showing 1 - 8 results of 8 for search 'Mark C. Genovese', query time: 0.03s
Refine Results
-
1
Long-term safety, immunogenicity and efficacy comparing FKB327 with the adalimumab reference product in patients with active rheumatoid arthritis: data from randomised double-blind... by Mark C Genovese, Rieke Alten, Herbert Kellner, Yasumasa Arai, Rafael Muniz
Published 2020-02-01
Article -
2
Long-term safety and efficacy of olokizumab in patients with rheumatoid arthritis and inadequate response to tumor necrosis factor inhibitor therapy in phase II studies by Mark C. Genovese, Patrick Durez, Roy Fleischmann, Yoshiya Tanaka, Daniel Furst, Hisashi Yamanaka, Elena Korneva, Igor Vasyutin, Tsutomu Takeuchi
Published 2021-07-01
Article -
3
Pooled analysis of TNF inhibitor biosimilar studies comparing radiographic progression by disease activity states in rheumatoid arthritis by Edward Keystone, Josef S Smolen, Paul Emery, Mark C Genovese, Michael E Weinblatt, Jung-Yoon Choe, Gihyun Myung, Evelyn Hong, Inyoung Baek, Jeehoon Ghil
Published 2020-02-01
Article -
4
Evaluation of hepatitis B virus in clinical trials of baricitinib in rheumatoid arthritis by Gerd Burmester, Tsutomu Takeuchi, Josef S Smolen, Mark C Genovese, Masayoshi Harigai, Kevin Winthrop, Yi-Ming Chen, Tsu-Yi Hsieh, Chad Walls, Wen-Shuo Wu, Christina Dickson, Ran Liao
Published 2020-02-01
Article -
5
Patient Perceptions of Unmet Medical Need in Rheumatoid Arthritis: A Cross-Sectional Survey in the USA by Christine Radawski, Mark C. Genovese, Brett Hauber, W. Benjamin Nowell, Kelly Hollis, Carol L. Gaich, Amy M. DeLozier, Kelly Gavigan, Maria Reynolds, Anabela Cardoso, Jeffrey R. Curtis
Published 2019-08-01
Article -
6
Safety and efficacy of switching from adalimumab to sarilumab in patients with rheumatoid arthritis in the ongoing MONARCH open-label extension by Gerd R Burmester, Mark C Genovese, Vibeke Strand, Gregory St John, Andrea Rubbert-Roth, Howard Amital, Tatiana Raskina, Antonio Gómez-Centeno, Claudia Pena-Rossi, Leon Gervitz, Karthinathan Thangavelu, Susan Boklage
Published 2019-10-01
Article -
7
Safety and efficacy of filgotinib in patients with rheumatoid arthritis: final results of the DARWIN 3 long-term extension study by Arthur Kavanaugh, Paul Emery, René Westhovens, Mark C Genovese, Kevin L Winthrop, Rieke Alten, Dick de Vries, Lorenzo Dagna, Patrick Verschueren, Maria Greenwald, Regina Cseuz, Robin Besuyen, Vikas Modgill, Ly Huong Le
Published 2025-01-01
Article -
8
Diminished cytokine-induced Jak/STAT signaling is associated with rheumatoid arthritis and disease activity. by Jason Ptacek, Rachael E Hawtin, Dongmei Sun, Brent Louie, Erik Evensen, Barbara B Mittleman, Alessandra Cesano, Guy Cavet, Clifton O Bingham, Stacey S Cofield, Jeffrey R Curtis, Maria I Danila, Chander Raman, Richard A Furie, Mark C Genovese, William H Robinson, Marc C Levesque, Larry W Moreland, Peter A Nigrovic, Nancy A Shadick, James R O'Dell, Geoffrey M Thiele, E William St Clair, Christopher C Striebich, Matthew B Hale, Houman Khalili, Franak Batliwalla, Cynthia Aranow, Meggan Mackay, Betty Diamond, Garry P Nolan, Peter K Gregersen, S Louis Bridges
Published 2021-01-01
Article